- Trials with a EudraCT protocol (133)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
133 result(s) found for: Saline injection.
Displaying page 6 of 7.
| EudraCT Number: 2016-004033-25 | Sponsor Protocol Number: PED-FQ-2016 | Start Date*: 2017-06-19 | ||||||||||||||||
| Sponsor Name:Fundació Parc Taulí | ||||||||||||||||||
| Full Title: Efect of nebulized bicarbonate on bacterial infections in patients with cystic fibrosis. Randomized clinical trial | ||||||||||||||||||
| Medical condition: Cystic Fibrosis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2012-005592-13 | Sponsor Protocol Number: FERRICHFII | Start Date*: 2014-02-27 | |||||||||||
| Sponsor Name:King's College London [...] | |||||||||||||
| Full Title: Mechanisms of Exercise Benefit with Intravenous Iron in Chronic Heart Failure: The Ferric Iron in Heart Failure (FERRIC HF) II Trial | |||||||||||||
| Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-004245-29 | Sponsor Protocol Number: 501 | Start Date*: 2008-12-08 | ||||||||||||||||
| Sponsor Name:R&D Dept Raigmore Hospital, Inverness | ||||||||||||||||||
| Full Title: Single Dose Dexamethasone following Aspiration of a Peri-tonsillar Abscess: A Randomised Placebo-Controlled Trial | ||||||||||||||||||
| Medical condition: Peri-tonsillar abscess is a common cause for emergency admission to an ENT ward. In Raigmore there are 2-3 admissions per week with a quinsy. The standard management is needle aspiration under loca... | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2010-021240-18 | Sponsor Protocol Number: ARHSG062010 | Start Date*: 2011-04-19 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA S. GERARDO DI MONZA | |||||||||||||
| Full Title: Peritoneal nebulization of Ropivacaine for pain control after laparoscopic colectomy | |||||||||||||
| Medical condition: Elective Laparoscopic colectomy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-002607-18 | Sponsor Protocol Number: 101.04 | Start Date*: 2012-08-30 | |||||||||||
| Sponsor Name:Marius Henriksen | |||||||||||||
| Full Title: COMBINED INTRA ARTICULAR CORTICOSTEROID AND EXERCISE IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE: A RANDOMISED TRIAL | |||||||||||||
| Medical condition: Knee Osteoarthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-000526-31 | Sponsor Protocol Number: BT2006003 | Start Date*: 2007-01-03 | |||||||||||
| Sponsor Name:Section of Clinical Pain Research, Department of Molecular Medicine and Surgery Karolinska Institute | |||||||||||||
| Full Title: Brush-evoked allodynia in patients with peripheral neuropathy before and following intravenous infusion of ondansetron. A randomised, double-blind, placebo controlled, cross-over study. | |||||||||||||
| Medical condition: Peripheral neuropathy | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-001859-40 | Sponsor Protocol Number: 2019-041 | Start Date*: 2020-11-05 | |||||||||||||||||||||||||||||||
| Sponsor Name:Franciscus Gasthuis & Vlietland | |||||||||||||||||||||||||||||||||
| Full Title: PEROPERATIVE TRANEXAMIC ACID IN BARIATRIC FAST TRACK SURGERY TO REDUCE HEMORRAGE RATES | |||||||||||||||||||||||||||||||||
| Medical condition: Morbid obesity | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2006-005667-26 | Sponsor Protocol Number: 130256 | Start Date*: 2007-07-11 | ||||||||||||||||
| Sponsor Name:Ninewells Hospital | ||||||||||||||||||
| Full Title: A randomised, placebo controlled trial of levobupivacaine or the combination of levobupivacaine and clonidine when administered as a sciatic perineural infusion for the prevention of phantom limb p... | ||||||||||||||||||
| Medical condition: Pain after amputation | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2007-002808-18 | Sponsor Protocol Number: AL0701rP | Start Date*: 2007-10-31 | ||||||||||||||||
| Sponsor Name:ALLERGOPHARMA JOACHIM GANZER KG | ||||||||||||||||||
| Full Title: A double-blind placebo controlled dose-response study for evaluation of safety and efficacy of immunotherapy with a cocktail of recombinant major allergens of Timothy Grass Pollen (Phleum pratense)... | ||||||||||||||||||
| Medical condition: ICD classification code: J45.0 and J30.1 | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2018-001582-16 | Sponsor Protocol Number: RF-2016-02361583 | Start Date*: 2018-08-09 | |||||||||||
| Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO | |||||||||||||
| Full Title: Efficacy of Albumin Replacement and Balanced Crystalloid Solutions in Septic Shock (the ALBIOSS-BALANCED trial): a 2-by-2 factorial, investigator-initiated, open-label, multicenter, randomized, con... | |||||||||||||
| Medical condition: Septic shock | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-005645-31 | Sponsor Protocol Number: 205540 | Start Date*: 2016-10-14 | |||||||||||
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
| Full Title: A randomised, double-blind (sponsor open) placebo-controlled, parallel group, 8-week treatment study to investigate the safety, pharmacodynamics, and effect of the TLR7 agonist, GSK2245035, on the... | |||||||||||||
| Medical condition: Mild allergic asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-005329-11 | Sponsor Protocol Number: FX006-2014-008 | Start Date*: 2015-02-26 | |||||||||||
| Sponsor Name:Flexion Therapeutics | |||||||||||||
| Full Title: A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients with Osteoarthritis of the Knee | |||||||||||||
| Medical condition: Osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) LT (Completed) EE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-000753-80 | Sponsor Protocol Number: 000298 | Start Date*: 2022-08-04 | |||||||||||
| Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
| Full Title: A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women underg... | |||||||||||||
| Medical condition: Infertility | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) CZ (Prematurely Ended) DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-004094-93 | Sponsor Protocol Number: PAFCUTIII | Start Date*: 2012-04-19 | |||||||||||
| Sponsor Name:Allergie-Centrum Charité | |||||||||||||
| Full Title: Double-blind, three-way cross-over, placebo controlled study to assess the efficacy, safety and mechanisms of treatment with rupatadine 20 and 40mg in cold contact urticaria (CCU) | |||||||||||||
| Medical condition: Cold contact urticaria | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-000966-12 | Sponsor Protocol Number: EL-004 | Start Date*: 2019-11-18 | |||||||||||
| Sponsor Name:Eloxx Pharmaceuticals Inc | |||||||||||||
| Full Title: A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients with Cystic Fibrosis... | |||||||||||||
| Medical condition: Cystic fibrosis (CF) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-005339-56 | Sponsor Protocol Number: CQGE031G12301 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Novartis Pharma AG | |||||||||||||
| Full Title: A 52 week, multi-center, randomized, double-blind placebo-controlled study to assess the clinical efficacy and safety of ligelizumab (QGE031) in decreasing the sensitivity to peanuts in patients wi... | |||||||||||||
| Medical condition: Allergy, Peanut | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Prematurely Ended) ES (Ongoing) DE (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-002783-40 | Sponsor Protocol Number: 000304 | Start Date*: 2019-07-04 | |||||||||||||||||||||||||||||||
| Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||||||||||||||||||||||
| Full Title: A randomised, controlled, open label, parallel group, multicentre trial comparing the efficacy and safety of individualised FE 999049 (follitropin delta) dosing, using a long GnRH agonist protocol ... | |||||||||||||||||||||||||||||||||
| Medical condition: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
| Trial protocol: AT (Completed) DK (Completed) NO (Completed) NL (Completed) IT (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2011-000480-27 | Sponsor Protocol Number: UCC-IGF-001 | Start Date*: 2011-06-03 | |||||||||||
| Sponsor Name:University College Cork | |||||||||||||
| Full Title: A Randomised Trial Evaluating the Safety and Efficacy of a Single Low Dose of Intracoronary Insulin-like Growth Factor-1 Following Percutaneous Coronary Intervention for ST-Elevation Acute Myocardi... | |||||||||||||
| Medical condition: ST Elevation Myocardial Infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IE (Completed) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-001923-53 | Sponsor Protocol Number: 7980 | Start Date*: 2015-10-07 | |||||||||||
| Sponsor Name:Rafael Bielza Galindo | |||||||||||||
| Full Title: Intravenous iron, early functional recovery and delirium in patients atients with hip fracture | |||||||||||||
| Medical condition: Hip fracture | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-008251-42 | Sponsor Protocol Number: 26014 | Start Date*: 2009-09-07 | ||||||||||||||||||||||||||
| Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||
| Full Title: Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN | ||||||||||||||||||||||||||||
| Medical condition: In this trial, the efficacy of Gardasil combined with imiquimod in women with usual type Vulvar Intraepithelial Neoplasia is investigated. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.